Google Alert - in

	in As-it-happens update ⋅ 19 October 2020
	WEB
	Forxiga recommended for approval in the EU by CHMP for heart failure AstraZeneca If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis